CY1118181T1 - Αναβραζοντα δισκια για χρηση σε εισπνοες - Google Patents
Αναβραζοντα δισκια για χρηση σε εισπνοεςInfo
- Publication number
- CY1118181T1 CY1118181T1 CY20161101120T CY161101120T CY1118181T1 CY 1118181 T1 CY1118181 T1 CY 1118181T1 CY 20161101120 T CY20161101120 T CY 20161101120T CY 161101120 T CY161101120 T CY 161101120T CY 1118181 T1 CY1118181 T1 CY 1118181T1
- Authority
- CY
- Cyprus
- Prior art keywords
- suspension
- restoreable
- discs
- drug
- particle size
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται στη χρήση αναβραζόντων δισκίων τα οποία περιέχουν αδιάλυτα δραστικά συστατικά για την παρασκευή εναιωρήματος για χρήση σε εισπνοές τα οποία διατηρούν το πρωτογενές μέγεθος σωματιδίων της φαρμακευτικής ουσίας. Τα δισκία διαλύονται στο διάλυμα έως ότου σχηματιστεί ένα εναιώρημα. Το εναιώρημα διατηρεί την αρχική κατανομή μεγέθους σωματιδίων της φαρμακευτικής ουσίας, εξασφαλίζοντας την επίτευξη του θεραπευτικού παραθύρου του εισπνεόμενου κλάσματος.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07110896 | 2007-06-22 | ||
EP08784529.3A EP2170348B1 (en) | 2007-06-22 | 2008-06-20 | Effervescent tablets for inhalatory use |
PCT/EP2008/004993 WO2009000473A2 (en) | 2007-06-22 | 2008-06-20 | Effervescent tablets for inhalatory use |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1118181T1 true CY1118181T1 (el) | 2017-06-28 |
Family
ID=40186078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20161101120T CY1118181T1 (el) | 2007-06-22 | 2016-11-03 | Αναβραζοντα δισκια για χρηση σε εισπνοες |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP2170348B1 (el) |
BR (1) | BRPI0814716A2 (el) |
CY (1) | CY1118181T1 (el) |
DK (1) | DK2170348T3 (el) |
EA (1) | EA021148B1 (el) |
ES (1) | ES2601860T3 (el) |
HR (1) | HRP20161388T1 (el) |
HU (1) | HUE030605T2 (el) |
LT (1) | LT2170348T (el) |
PL (1) | PL2170348T3 (el) |
PT (1) | PT2170348T (el) |
SI (1) | SI2170348T1 (el) |
WO (1) | WO2009000473A2 (el) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1921919B1 (en) | 2005-07-14 | 2012-04-04 | Lithera, Inc. | Sustained release enhanced lipolytic formulation for regional adipose tissue treatment |
ATE498396T1 (de) * | 2008-07-21 | 2011-03-15 | Falk Pharma Gmbh | Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes |
US9132084B2 (en) | 2009-05-27 | 2015-09-15 | Neothetics, Inc. | Methods for administration and formulations for the treatment of regional adipose tissue |
GB2477030A (en) * | 2010-01-15 | 2011-07-20 | Lithera Inc | Lyophilised forms of fluticasone, salmeterol and combinations thereof |
CN105832681A (zh) | 2010-11-24 | 2016-08-10 | 纽赛蒂克斯公司 | 选择性、亲脂性及长效型β激动剂单一治疗调配物和用于肥胖及外形凸起的美容治疗的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1438019A1 (en) * | 2001-10-24 | 2004-07-21 | PARI GmbH Spezialisten für effektive Inhalation | Kit for the preparation of a pharmaceutical composition |
ITMI20020808A1 (it) * | 2002-04-17 | 2003-10-17 | Chiesi Farma Spa | Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione |
US20040045546A1 (en) * | 2002-09-05 | 2004-03-11 | Peirce Management, Llc | Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use |
ITFI20030194A1 (it) * | 2003-07-17 | 2005-01-18 | Menarini Int Operations Lu Sa | Composizione farmaceutiche effervescenti contenenti |
-
2008
- 2008-06-20 EA EA200971113A patent/EA021148B1/ru not_active IP Right Cessation
- 2008-06-20 LT LTEP08784529.3T patent/LT2170348T/lt unknown
- 2008-06-20 HU HUE08784529A patent/HUE030605T2/hu unknown
- 2008-06-20 SI SI200831692A patent/SI2170348T1/sl unknown
- 2008-06-20 DK DK08784529.3T patent/DK2170348T3/en active
- 2008-06-20 PT PT87845293T patent/PT2170348T/pt unknown
- 2008-06-20 EP EP08784529.3A patent/EP2170348B1/en not_active Not-in-force
- 2008-06-20 ES ES08784529.3T patent/ES2601860T3/es active Active
- 2008-06-20 PL PL08784529T patent/PL2170348T3/pl unknown
- 2008-06-20 BR BRPI0814716-7A2A patent/BRPI0814716A2/pt not_active IP Right Cessation
- 2008-06-20 WO PCT/EP2008/004993 patent/WO2009000473A2/en active Application Filing
-
2016
- 2016-10-25 HR HRP20161388TT patent/HRP20161388T1/hr unknown
- 2016-11-03 CY CY20161101120T patent/CY1118181T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK2170348T3 (en) | 2016-11-07 |
EP2170348B1 (en) | 2016-08-10 |
EA021148B1 (ru) | 2015-04-30 |
PT2170348T (pt) | 2016-11-02 |
EP2170348A2 (en) | 2010-04-07 |
SI2170348T1 (sl) | 2016-12-30 |
WO2009000473A3 (en) | 2009-07-30 |
ES2601860T3 (es) | 2017-02-16 |
HRP20161388T1 (hr) | 2016-12-02 |
EA200971113A1 (ru) | 2010-04-30 |
HUE030605T2 (hu) | 2017-05-29 |
BRPI0814716A2 (pt) | 2015-02-24 |
LT2170348T (lt) | 2016-11-25 |
PL2170348T3 (pl) | 2017-01-31 |
WO2009000473A2 (en) | 2008-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118181T1 (el) | Αναβραζοντα δισκια για χρηση σε εισπνοες | |
CY1114215T1 (el) | Φαρμακευτικες συνθεσεις διαλυματος για υπο πιεση εισπνευστηρες μετρουμενης δοσης | |
CY1118813T1 (el) | Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων | |
EA201200937A1 (ru) | Твердая лекарственная форма тикагрелора | |
MX2014009757A (es) | Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia. | |
MX2012012438A (es) | Formulaciones farmaceuticas que comprenden pioglitazona y linagliptina. | |
EA201590449A1 (ru) | Перорально вводимая лекарственная композиция | |
UY30438A1 (es) | Derivados n-sustituidos de 5-halo-4-[2-alquil-1-sustituidos-1h-imidazol-5-il]pirimidin-2-amina, composiciones-procesos para su preparacion y usos | |
PH12015502539B1 (en) | Cenicriviroc compositions and methods of making and using the same | |
MX2011008634A (es) | Derivados de aminotetralina composiciones farmaceuticas que los contienen y su uso en terapia. | |
MX2010005631A (es) | Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades. | |
EA201391087A1 (ru) | Оральные лекарственные формы препарата тазоцитиниба с модифицированным высвобождением | |
EA201491285A1 (ru) | Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты | |
UA106634C2 (uk) | Тверда фармацевтична дозована форма | |
CU20110208A7 (es) | Derivados de la piridina de tieno (2,3-b) como inhibidores virales de la réplica | |
EA201200618A1 (ru) | Производные хроменона с антиопухолевой активностью | |
MY165149A (en) | Use of binders for manufacturing storage stable formulations | |
BR112015018168A2 (pt) | inibidores de rock suaves | |
EA201490653A1 (ru) | Производные эстра-1,3,5(10),16-тетраен-3-карбоксамида, способ их получения, содержащие их фармацевтические препараты, а также их применение для получения лекарственных средств | |
TR200900878A2 (tr) | Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar | |
UA104988C2 (uk) | Похідні піроніндолу та спосіб їх отримання | |
EA201491479A1 (ru) | Производные лупановых тритерпеноидов и их фармацевтическое применение | |
WO2013147649A3 (ru) | ИНГИБИТОРЫ СИГНАЛЬНОГО ПУТИ PI3K/AKT/IKK/NF-kB, ИХ ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ И СОДЕРЖАЩИЕ ИХ КОМПОЗИЦИИ ДЛЯ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ ВИРУСНЫХ ЗАБОЛЕВАНИЙ | |
EA201590697A1 (ru) | Производные кетамина | |
PH12015500823A1 (en) | Modified release formulations for oprozomib |